A

Avadel Pharmaceuticals plc
D

AVDL

11.650
USD
-0.02
(-0.13%)
Market Closed
Volume
54,291
EPS
-0
Div Yield
-
P/E
-16
Market Cap
1,122,611,801
OverviewSignalsIdeasNews
Related Instruments
    A
    AGIO
    -1.645
    (-2.97%)
    53.810 USD
    B
    BLUE
    -0.04270
    (-11.74%)
    0.32090 USD
    B
    BPMC
    -6.990
    (-7.31%)
    88.690 USD
    E
    EXEL
    -0.600
    (-1.71%)
    34.450 USD
    G
    GTHX
    0.01000
    (0.14%)
    7.16000 USD
    I
    INCY
    -1.840
    (-2.37%)
    75.890 USD
    M
    MRTX
    0
    (0%)
    0.000000 USD
    P
    PBYI
    -0.57500
    (-19.23%)
    2.41500 USD
    More
News

Title: Avadel Pharmaceuticals plc

Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Avadel Pharmaceuticals PLC is a specialty pharmaceutical company. It identifies, develops, and commercializes branded pharmaceutical products including controlled-release therapeutic products based on its proprietary drug delivery technologies in the United States. The company is engaged in development of differentiated drug products for administration in various forms such as capsules, tablets, injectables etc. Its commercialized product LUMRYZ is an extended-release formulation of sodium oxybate indicated to be taken once at bedtime for the treatment of cataplexy or EDS in adults with narcolepsy.